Syntara Ltd: Equity Raising Presentation
Syntara Ltd: Presentation: Phase 2 study of SNT-5505 in myelofibrosis
Syntara Ltd: Results of Meeting
Syntara Ltd: CEO AGM Presentation to Shareholders
Syntara Ltd: Presentation for September Quarterly Shareholder Update
Syntara Ltd: Quarterly Activities Report
Syntara Ltd: Notice of Annual General Meeting/Proxy Form
Syntara Ltd: Investor Presentation - Updated
Syntara Ltd: Date of 2024 AGM and closing date for director nomination
Syntara Ltd: Results of Meeting
Syntara Ltd: Notice of General Meeting/Proxy Form
Syntara Ltd: Equity Raising Presentation
Syntara Ltd: Investor presentation
Syntara Ltd: Updated company investor presentation
Syntara Ltd: Presentation for quarterly shareholder briefing
Syntara Ltd: Investor presentation - NWR Virtual Healthcare Conference
Syntara Ltd: Investor Presentation
Syntara Ltd: Investor presentation - Euroz Hartley Healthcare Conference
Syntara Ltd: Quarterly investor presentation
Syntara Ltd: Results of Meeting